Literature DB >> 20576235

Using tests for recent infection to estimate incidence: problems and prospects for HIV.

A Welte1, T A McWalter, O Laeyendecker, T B Hallett.   

Abstract

Tests for recent infection (TRIs), such as the BED assay, provide a convenient way to estimate HIV incidence rates from cross-sectional survey data. Controversy has arisen over how the imperfect performance of a TRI should be characterised and taken into account. Recent theoretical work is providing a unified framework within which to work with a variety of TRI- and epidemic-specific assumptions in order to estimate incidence using imperfect TRIs, but suggests that larger survey sample sizes will be required than previously thought. This paper reviews the framework qualitatively and provides examples of estimator performance, identifying the characteristics required by a TRI to estimate incidence reliably that should guide the future development of TRIs.

Entities:  

Mesh:

Year:  2010        PMID: 20576235      PMCID: PMC2937566     

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  29 in total

1.  Should biomarker estimates of HIV incidence be adjusted?

Authors:  Ron Brookmeyer
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

2.  Relating recent infection prevalence to incidence with a sub-population of assay non-progressors.

Authors:  Thomas Andrew McWalter; Alex Welte
Journal:  J Math Biol       Date:  2009-07-25       Impact factor: 2.259

3.  Reply to 'Should biomarker estimates of HIV incidence be adjusted?'.

Authors:  Alex Welte; Thomas A McWalter; Till Bärnighausen
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

4.  BED estimates of HIV incidence must be adjusted.

Authors:  J Steven McDougal
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

5.  Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe.

Authors:  Timothy B Hallett; Simon Gregson; Owen Mugurungi; Elizabeth Gonese; Geoff P Garnett
Journal:  Epidemics       Date:  2009-03-20       Impact factor: 4.396

6.  Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.

Authors:  Edmore T Marinda; John Hargrove; Wolfgang Preiser; Hannes Slabbert; Gert van Zyl; Jonathan Levin; Lawrence H Moulton; Alex Welte; Jean Humphrey
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04-01       Impact factor: 3.731

Review 7.  HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis.

Authors:  Till Bärnighausen; Thomas A McWalter; Zachary Rosner; Marie-Louise Newell; Alex Welte
Journal:  Epidemiology       Date:  2010-09       Impact factor: 4.822

8.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Authors:  R S Janssen; G A Satten; S L Stramer; B D Rawal; T R O'Brien; B J Weiblen; F M Hecht; N Jack; F R Cleghorn; J O Kahn; M A Chesney; M P Busch
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

9.  Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age.

Authors:  Timothy B Hallett; Peter Ghys; Till Bärnighausen; Ping Yan; Geoff P Garnett
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

10.  A comparison of biomarker based incidence estimators.

Authors:  Thomas A McWalter; Alex Welte
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more
  27 in total

1.  Strengthening HIV surveillance: measurements to track the epidemic in real time.

Authors:  Usangiphile E Buthelezi; Candace L Davidson; Ayesha Bm Kharsany
Journal:  Afr J AIDS Res       Date:  2016-07       Impact factor: 1.300

2.  Short Communication: Defining optimality of a test for recent infection for HIV incidence surveillance.

Authors:  Reshma Kassanjee; Thomas A McWalter; Alex Welte
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-26       Impact factor: 2.205

3.  A new general biomarker-based incidence estimator.

Authors:  Reshma Kassanjee; Thomas A McWalter; Till Bärnighausen; Alex Welte
Journal:  Epidemiology       Date:  2012-09       Impact factor: 4.822

4.  Workshop summary: Novel biomarkers for HIV incidence assay development.

Authors:  Usha K Sharma; Marco Schito; Alex Welte; Christine Rousseau; Joseph Fitzgibbon; Brandon Keele; Stuart Shapiro; Andrew McMichael; David N Burns
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-24       Impact factor: 2.205

Review 5.  How can we better identify early HIV infections?

Authors:  Nora E Rosenberg; Christopher D Pilcher; Michael P Busch; Myron S Cohen
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

6.  Decreased specificity of an assay for recent infection in HIV-1-infected patients on highly active antiretroviral treatment: implications for incidence estimates.

Authors:  Antoine Chaillon; Stéphane Le Vu; Sylvie Brunet; Guillaume Gras; Frédéric Bastides; Louis Bernard; Laurence Meyer; Francis Barin
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

7.  Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.

Authors:  Oliver Laeyendecker; Jessica D Church; Amy E Oliver; Anthony Mwatha; S Michele Owen; Deborah Donnell; Ron Brookmeyer; Philippa Musoke; J Brooks Jackson; Laura Guay; Clemesia Nakabiito; Thomas C Quinn; Susan H Eshleman
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

8.  Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.

Authors:  Reshma Kassanjee; Christopher D Pilcher; Michael P Busch; Gary Murphy; Shelley N Facente; Sheila M Keating; Elaine Mckinney; Kara Marson; Matthew A Price; Jeffrey N Martin; Susan J Little; Frederick M Hecht; Esper G Kallas; Alex Welte
Journal:  AIDS       Date:  2016-09-24       Impact factor: 4.177

9.  Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay.

Authors:  Andrew F Longosz; Shruti H Mehta; Gregory D Kirk; Joseph B Margolick; Joelle Brown; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

10.  Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age.

Authors:  Timothy B Hallett; Peter Ghys; Till Bärnighausen; Ping Yan; Geoff P Garnett
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.